Revitope Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Revitope's estimated annual revenue is currently $1.7M per year.(i)
  • Revitope's estimated revenue per employee is $284,167

Employee Data

  • Revitope has 6 Employees.(i)
  • Revitope grew their employee count by -33% last year.

Revitope's People

NameTitleEmail/Phone
1
Executive Chairman, FounderReveal Email/Phone
2
Associate Principal Scientist IO DiscoveryReveal Email/Phone
3
Principal ScientistReveal Email/Phone
4
Research AssistantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M1-50%N/AN/A
#3
$5.1M3322%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M2-60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
N/A1110%N/AN/A
#10
$5.4M290%N/AN/A
Add Company

What Is Revitope?

Revitope is an early stage biotechnology company focused on developing the next-generation of T cell redirecting biologics. Immune-based therapies are redefining how cancer is treated as clinical studies demonstrate unprecedented deep and durable responses in multiple cancers. In particular redirecting T cells to tumors is a successful strategy for immunotherapy of liquid tumors. However, unleashing a potent immune response that is entirely focused on the tumor continues to be elusive. Revitope is developing a new class of biologic prodrugs we call Programmable Antibody Circuits or PACs that are engineered to focus immune activation to the cancer cell surface while expanding the antigenic targeting space.

keywords:N/A

N/A

Total Funding

6

Number of Employees

$1.7M

Revenue (est)

-33%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.4M6N/AN/A
#2
$0.1M6-14%$24M
#3
$0.4M6N/AN/A
#4
$0.4M6N/AN/A
#5
$0.4M6N/AN/A